Search

To the Editor, Bladder cancer is one of the most common cancers in humans, representing the 7th and 17th type of neoplasm in both genders. Its incidence and mortality are quite heterogeneous in different countries and are due to different risk factors, quality and prevalence of healthcare and the possibility of early diagnosis and treatment of the tumor and its potential recurrences. [...]

This article discusses the management of Non-Muscle Invasive Bladder Cancer (NMIBC) in an office-based setting. It emphasizes the importance of early detection and treatment for better outcomes. The article suggests that office-based procedures like fulguration and laser vaporization can be effective and cost-saving alternatives to hospitalization for transurethral resection of the bladder (TURB). However, more research is needed to determine the ideal candidates for these procedures and to strengthen the scientific evidence. The document provides a list of references for a study conducted in Italy, covering various treatment approaches, cost-effectiveness, biomarkers, and factors affecting survival rates. [Extracted from the article]